Document Detail

Oral contraceptive use and breast cancer risk in young women. UK National Case-Control Study Group.
MedLine Citation:
PMID:  2565515     Owner:  NLM     Status:  MEDLINE    
All women diagnosed with breast cancer before age 36 in eleven geographical areas in Britain were included in a case-control study designed to investigate the relation between oral contraceptive (OC) use and breast cancer risk. 755 cases each with a matched control were interviewed in their homes by trained interviewers. General practitioner notes and family planning clinic records were abstracted and combined with the interview data. There was a highly significant trend in risk of breast cancer with total duration of OC use with relative risks of 1.43 (95% confidence interval 0.97-2.12) for 49-96 months use, and 1.74 (95% confidence interval 1.15-2.62) for 97 or more months use. The relative risks were similar for use before and after first full-term pregnancy. There is some evidence that OCs containing less than 50 micrograms oestrogen have a lower risk associated with their use than higher oestrogen dose OCs and that there may be some protective effect of use of progestagen-only pills. These apparent differences between OC types are only marginally significant statistically and need further investigation. Extensive investigations of possible bias using data abstracted from general practitioner notes for both interviewed and non-interviewed cases and controls demonstrate that biases cannot explain these results although some relative risks may be slightly exaggerated. There is, however, no support for these findings in national breast cancer registration rates which are not increasing.
Related Documents :
12744425 - Women's knowledge and sources of information on the risks and benefits of oral contrace...
21079445 - Women and anabolic steroids: an analysis of a dozen users.
8178905 - Clinical and metabolic features of desogestrel: a new oral contraceptive preparation.
14969675 - Oral contraceptive use and risk of diabetes among chinese women.
11956645 - Cyp3a4 promoter variant is associated with prostate cancer risk in men with benign pros...
9490235 - Plasma concentration of c-reactive protein and risk of developing peripheral vascular d...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Lancet     Volume:  1     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1989 May 
Date Detail:
Created Date:  1989-06-06     Completed Date:  1989-06-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  973-82     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Breast Neoplasms / chemically induced*,  epidemiology,  pathology,  psychology
Cohort Studies
Contraceptives, Oral / adverse effects*,  classification
Contraceptives, Oral, Combined / adverse effects
Drug Evaluation
Great Britain
Interview, Psychological
Neoplasm Staging
Research Design
Risk Factors
Time Factors
Reg. No./Substance:
0/Contraceptives, Oral; 0/Contraceptives, Oral, Combined
Comment In:
Lancet. 1989 Jul 8;2(8654):97-8   [PMID:  2567887 ]
Lancet. 1989 Jul 15;2(8655):158   [PMID:  2567919 ]
Lancet. 1989 Nov 11;2(8672):1163-4   [PMID:  2572891 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Relative weight and major ischaemic heart disease events in hypertensive men.
Next Document:  Association between biological properties of human immunodeficiency virus variants and risk for AIDS...